To ascertain whether tumor cell vaccine expressing PD-1 antibody still showed high biological activity after irradiation, we collected the supernatants of irradiated group and sorted CD8+PD-1− and CD8+PD-1+ TIL cells separately in CT26 tumor, labeled them with CFSE in vitro. The gene discussed is CD8A; the disease is neoplasm.